Recognizing the extraordinary resilience and courage of children and families fighting neuroblastoma and supports the incredible effort of clinicians and researchers working to address this disease and expressing support for September 3, 2026, to be designated as "Neuroblastoma Awareness Day".

Designates September 3, 2026 as Neuroblastoma Awareness Day to spotlight a deadly childhood cancer and promote earlier diagnosis and more research. Neuroblastoma is the most common cancer in infants, with about 600–800 U.S. cases each year. It represents roughly 8–10% of childhood cancers and about 15% of childhood cancer deaths. About 90% of cases are diagnosed before age 5. High-risk disease has an approximate 63% five-year survival and requires intensive multimodal treatment. Survivors can face lifelong complications. The resolution seeks to recognize families and encourage investment in treatments and research.